A retrospective cross-sectional survey on nosocomial bacterial infections and their antimicrobial susceptibility patterns in hospitalized patients in northwest of Iran by Sadeghi, Hamid et al.
Sadeghi et al. BMC Res Notes           (2021) 14:88  
https://doi.org/10.1186/s13104-021-05503-0
RESEARCH NOTE
A retrospective cross-sectional survey 
on nosocomial bacterial infections and their 
antimicrobial susceptibility patterns 
in hospitalized patients in northwest of Iran
Hamid Sadeghi1, Saeideh Gholamzadeh Khoei2, Mehdi Bakht3, Mohammad Rostamani3, Sara Rahimi3, 
Mehdi Ghaemi4 and Bahman Mirzaei1,5* 
Abstract 
Objective: Nosocomial infections (NIs) are known as one of the remarkable problems in all countries. This study is 
aimed to estimate the prevalence rate of nosocomial bacterial agents with antimicrobial susceptibility pattern in hos-
pitalized patients. This study was conducted from April 2017 to September 2018, on 4029 hospitalized patients. We set 
out to recognize the commonest bacterial infections and antimicrobial susceptibility patterns of nosocomial infection.
Results: Of the 4029 patients, 509 (12.6%) of them were culture positive. Of these Escherichia coli (E. coli) (98.3%) and 
Staphylococcus epidermidis (S. epidermidis) (37.5%) were the most abundant bacterial identified in the urinary tract and 
bloodstream cultures respectively, Moreover, Acinetobacter spp. (100%) and Pseudomonas aeruginosa (22.2%) were the 
most abundant organisms detected in the respiratory system. According to susceptibility testing results, 370 (80.5%) 
and 264 (57.3%) in Gram-negatives and 44 (91.7%) and 35 (72.9%) in gram positives isolated strains were classified as 
multidrug-resistant (MDR) and extensive drug-resistant (XDR) strain respectively. On account of the high prevalence of 
MDR and XDR bacterial species, there is a pressing need for the expansion of new strategies on antibiotic supervision 
and infection control to introduce new guideline on empirical antibiotic therapy.
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Introduction
Nosocomial infections (NIs) are known as hospital-
gained infection expanding within 48–72 h after incom-
ing [1]. A large part of morbidity and mortality in 
hospitals goes back to the NIs [2]. Following the increas-
ing rate of NIs, developing in socio-economic distur-
bance, antimicrobial resistance, and the mortality rate 
are inevitable [3]. NIs happen throughout the world both 
in developing and developed countries. NIs accounts for 
10% in developing and 7% in developed countries [4]. 
Nearly 2 million people have been tangled in this matter 
and also would be known as a major reason for the loss 
of life and money [5]. Bacteria are hugely the prominent 
cause of NIs [6]. The most usual kinds of NIs which hap-
pen in a hospital set up are: urinary system, bloodstream 
infections, surgical site infections, gastroenteritis, res-
piratory system [7, 8]. Despite global endeavor to rein 
NIs during previous years, NIs still stays a widespread 
problem and as one of the important causes of antibiotic 
resistance in hospitalized patients [9]. As antibiotic resist-
ance continues to greaten, attuned definitions with which 
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